KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Equity Ratio (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Equity Ratio for 17 consecutive years, with 0.7 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio changed 0.45% to 0.7 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.7, a 0.45% change, with the full-year FY2025 number at 0.7, changed 0.45% from a year prior.
  • Equity Ratio was 0.7 for Q4 2025 at Bio-Rad Laboratories, up from 0.69 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 37.65 in Q4 2021 to a low of 0.69 in Q3 2025.
  • A 5-year average of 7.26 and a median of 0.71 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: soared 4838.46% in 2021, then crashed 98.11% in 2022.
  • Bio-Rad Laboratories' Equity Ratio stood at 37.65 in 2021, then plummeted by 98.11% to 0.71 in 2022, then skyrocketed by 4175.3% to 30.45 in 2023, then plummeted by 97.7% to 0.7 in 2024, then increased by 0.45% to 0.7 in 2025.
  • Per Business Quant, the three most recent readings for BIO's Equity Ratio are 0.7 (Q4 2025), 0.69 (Q3 2025), and 0.7 (Q2 2025).